Fischer Medical Ventures share news and announcements
NSE: FISCHERBSE: 524743Healthcare Equipment & SuppliesSmall Cap
Share price at the NSE close on 23 Oct 2026. Previous close ₹23.87.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹1,738 Cr1,073rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 14 Aug 2026
- 58.1
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet.
- Shares changed
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.20%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 14 Aug 2026
- 8.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 14 Aug 2026
- 10.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 31 May 2026
- 0.19
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 91,74,21521.6% delivered
Last results date
The last board meeting held for results; the company has not yet given notice of the next.Fischer Medical Ventures quarterly results
The board met on 14 Aug 2026 to consider financial results
Notice filed 7 Aug 2026
To consider and approve the financial results for the period ended Jun 30, 2026 (opens in a new tab)
Fischer Medical Ventures annual reports, presentations and earnings calls
The company's own documents, latest first.Fischer Medical Ventures financials, year by year
Annual reports2
Investor presentations1
- Presentation (opens in a new tab)7 Sep 2026
Earnings calls2
- Transcript (opens in a new tab)13 Nov 2025
- Link of Recording (opens in a new tab)7 Nov 2025
Fischer Medical Ventures share news and announcements
110 announcements, routine notices left out, newest first. Page 1 of 3.
Oct 2026
16 Oct · General Updates
14 Oct · Board meeting
Sep 2026
26 Sep · Corrigendum
25 Sep · Board meeting
17 Sep · Updates
16 Sep · Updates
4 Sep · Analysts
3 Sep · General Updates
3 Sep · Corporate action
Aug 2026
17 Aug · General Updates
15 Aug · Management
15 Aug · Management
14 Aug · General Updates
14 Aug · Management
13 Aug · General Updates
12 Aug · General Updates
11 Aug · General Updates
Jul 2026
Jun 2026
25 Jun · Legal
Exchange has sought clarification from Fischer Medical Ventures Limited for the quarter ended 31-Mar-2026 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results not submitted within 30 minutes or 3 hours from the end of board meeting (as may be applicable). -2. Segment details not submitted. The response of the Company is awaited.
May 2026
Apr 2026
Mar 2026
24 Mar · Board meeting
Feb 2026
12 Feb · Business
4 Feb · Legal
Exchange has sought clarification from Fischer Medical Ventures Limited for the quarter ended 31-Dec-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Segment details not submitted. The response of the Company is awaited.
Jan 2026
30 Jan · Disclosure of material issue
30 Jan · Board meeting
How the price met the news
The first session after each announcement, beside the market. Moves to 29 May 2025 are on BSE closes, before the company traded on NSE.
That dayThe first session's move. The first session's close after the announcement against the close before it, as a per cent change, on prices adjusted for splits and bonuses.Against the Nifty 500Against the Nifty 500. The share's move less the Nifty 500's move the same session, in percentage points (pts).Market median on that newsThe market's median move on that news. The middle first-session move of every listed company that filed the same kind of announcement, half moving more and half less.Five sessionsFive sessions' move. The close five sessions after the announcement against the close before it, as a per cent change.Five sessions against the Nifty 500Five sessions against the Nifty 500. The share's five-session move less the Nifty 500's move over the same five sessions, in percentage points (pts).Volume, times usualVolume, times usual. The session's shares traded divided by the average of the twenty sessions before it.Delivery against usualDelivery against usual. The share of the session's volume delivered into demat accounts, rather than bought and sold again the same day, less its average over the twenty sessions before, in percentage points (pts).
- 17 Aug 2026Resultsdown 3.55%−3.4 pts vs Nifty 500market median −0.7% · five sessions −1.3% (−1.0 pts vs Nifty 500) · volume 0.3× usual · delivery +16.3 pts against usual · The announcement (opens in a new tab)
- 17 Aug 2026Board or managers changeddown 3.55%−3.4 pts vs Nifty 500market median 0.0% · five sessions −1.3% (−1.0 pts vs Nifty 500) · volume 0.3× usual · delivery +16.3 pts against usual · The announcement (opens in a new tab)
- 1 Jun 2026Resultsdown 4.98%−4.0 pts vs Nifty 500market median −0.7% · five sessions −12.4% (−11.5 pts vs Nifty 500) · volume 0.1× usual · delivery +72.9 pts against usual · The announcement (opens in a new tab)
- 6 Feb 2026Pledgeup 5.00%+4.9 pts vs Nifty 500market median −0.2% · five sessions +1.0% (−0.1 pts vs Nifty 500) · volume 1.1× usual · delivery +1.6 pts against usual · The announcement (opens in a new tab)
- 1 Feb 2026Resultsdown 2.54%−0.5 pts vs Nifty 500market median −0.7% · five sessions +9.2% (+7.7 pts vs Nifty 500) · volume 1.2× usual · delivery −1.1 pts against usual · The announcement (opens in a new tab)
- 18 Aug 2025Board or managers changedup 1.03%−0.1 pts vs Nifty 500market median 0.0% · five sessions +4.8% (+3.4 pts vs Nifty 500) · volume 0.3× usual · delivery −9.0 pts against usual · The announcement (opens in a new tab)
- 14 Aug 2025Resultsup 3.95%+4.0 pts vs Nifty 500market median −0.7% · five sessions +9.2% (+7.2 pts vs Nifty 500) · volume 3.3× usual · delivery −23.0 pts against usual · The announcement (opens in a new tab)
- 29 May 2025Dividendup 0.27%−0.1 pts vs Nifty 500market median 0.0% · five sessions −0.1% (−0.2 pts vs Nifty 500) · volume 2.5× usual · The announcement (opens in a new tab)
Fischer Medical Ventures results filing dates and deadlines
Listed companies must file quarterly results within 45 days, and the year's within 60.
Days to fileDays to file. The days from the period's end to the day the results reached the exchange.DeadlineDeadline, days. The days the rules allow from the period's end: 45 for a quarter or half year, and 60 for the year and the March quarter filed with it. A company that listed after the period ended has until 21 days after its listing where that is later.
Figures filed again
The latest 30. Lines the company later filed with a different value, rupee lines in ₹ crore and per-share lines in rupees.
| Line | Period | Accounts | First filed | Filed again | Change. The value filed again less the value first filed, as a per cent of the first. | First filed on | Filed again on |
|---|---|---|---|---|---|---|---|
| Assets turning to cash within a year | At Mar 2026 | Consolidated | 413.74 | 417.59 | +0.9% | 30 May 2026 (opens in a new tab) | 31 May 2026 (opens in a new tab) |
| Total assets | At Mar 2026 | Consolidated | 672.00 | 671.01 | −0.1% | 30 May 2026 (opens in a new tab) | 31 May 2026 (opens in a new tab) |
| Other assets turning to cash within a year | At Mar 2026 | Consolidated | 84.49 | 84.49 | 0.0% | 30 May 2026 (opens in a new tab) | 31 May 2026 (opens in a new tab) |
| Total income | Year to date to Mar 2026 | Consolidated | 320.89 | 320.89 | 0.0% | 30 May 2026 (opens in a new tab) | 31 May 2026 (opens in a new tab) |
| Other income | Year to date to Mar 2026 | Consolidated | 12.31 | 12.31 | 0.0% | 30 May 2026 (opens in a new tab) | 31 May 2026 (opens in a new tab) |
| Other expenses | Quarter to Mar 2026 | Consolidated | 24.24 | 24.24 | 0.0% | 30 May 2026 (opens in a new tab) | 31 May 2026 (opens in a new tab) |
| Employee costs | Quarter to Mar 2026 | Consolidated | 4.02 | 4.02 | 0.0% | 30 May 2026 (opens in a new tab) | 31 May 2026 (opens in a new tab) |
| Finance costs | Year to date to Mar 2026 | Consolidated | 5.83 | 5.83 | 0.0% | 30 May 2026 (opens in a new tab) | 31 May 2026 (opens in a new tab) |
| Finance costs | Quarter to Mar 2026 | Consolidated | 3.61 | 3.61 | 0.0% | 30 May 2026 (opens in a new tab) | 31 May 2026 (opens in a new tab) |
| Other financial assets due within a year | At Mar 2026 | Consolidated | 2.65 | 6.50 | +145.2% | 30 May 2026 (opens in a new tab) | 31 May 2026 (opens in a new tab) |